H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2350 per share of common stock, payable on February 19, 2026 to shareholders...
Q4 2025 Net income of $30 million; Adjusted EBITDA of $170 million, up 15% year-on-year Q4 2025 Adjusted EBITDA margin of 19.0%, up 290 basis points year-on-year ...
H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month and twelve-month fiscal periods ended November 29, 2025, in a press release issued after the market close...
This new platform aligns philanthropic investments with youth leadership and STEM-focused initiatives to empower the next generation and support thriving global communities
Appointment reinforces H.B. Fuller’s innovation strategy and expansion into medical adhesive technologies Celine Martin, a seasoned medical device executive,...
H.B. Fuller Company (NYSE: FUL) today announced that it is hosting its 2025 Investor Day live and by webcast on Monday, October 20, 2025, at the Conrad New York Downtown Hotel in New York, NY. The conference...
H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2350 per share of common stock, payable on October 30, 2025 to shareholders...
Reported EPS (diluted) of $1.22; Adjusted EPS (diluted) of $1.26, up 12% year-on-year Net income of $67 million; Adjusted EBITDA of $171 million, up 3% year-on-year ...
H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month fiscal period ended August 30, 2025, in a press release issued after the market close on September 24,...
H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2350 per share of common stock, payable on August 14, 2025 to shareholders of...